Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1REGN88----1件: 46 💬
2SAR153191 (REGN88)1件: Sarilumab (REGN88)1件: Sarilumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
3Sarilumab SAR153191 (REGN88)1件: Sarilumab (REGN88)1件: Sarilumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107 💬
4SarilumabProduct Code: SAR153191 (REGN88)Pharmaceutical Form: Solution for injectionINN or Proposed INN: SARILUMABCurrent Sponsor code: SAR153191Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 175-----1件: 107 💬